Akouos, Inc.
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Aug 2037
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jan 11, 2027The maintenance fee for Aav-Mediated Delivery of Therapeutic Antibodies to the Inner Ear (US 11,697,801) comes due Jan 11, 2027. Unpaid by Jul 12, 2027, it lapses early.
- 1 fee due Apr 10, 2027The maintenance fee for Compositions and Methods for Treating Non-Age-Associated Hearing Impairment in a Human Subject (US 11,781,145) comes due Apr 10, 2027. Unpaid by Oct 12, 2027, it lapses early.
- 1 fee due May 7, 2027The maintenance fee for Compositions and Methods for Treating Non-Age-Associated Hearing Impairment in a Human Subject (US 11,807,867) comes due May 7, 2027. Unpaid by Nov 8, 2027, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,201,455 | System for Inner Ear Drug Delivery via Trans-Round Window Membrane Injection In force · High confidence | In force | High confidence | |
| US 11,298,267 | System for Inner Ear Drug Delivery via Trans-Round Window Membrane Injection In force · High confidence | In force | High confidence | |
| US 11,525,139 | Compositions and Methods for Treating Non-Age-Associated Hearing Impairment in a Human Subject In force · Medium confidence | In force | Medium confidence | |
| US 11,781,145 | Compositions and Methods for Treating Non-Age-Associated Hearing Impairment in a Human Subject In force · Medium confidence | In force | Medium confidence | |
| US 12,264,317 | Compositions and Methods for Treating Non-Age-Associated Hearing Impairment in a Human Subject In force · Medium confidence | In force | Medium confidence | |
| US 11,697,801 | Aav-Mediated Delivery of Therapeutic Antibodies to the Inner Ear In force · Medium confidence | In force | Medium confidence | |
| US 12,077,783 | Aav-Mediated Delivery of Antibodies to the Inner Ear In force · High confidence | In force | High confidence | |
| US 12,275,960 | Aav-Mediated Delivery of Therapeutic Antibodies to the Inner Ear In force · High confidence | In force | High confidence | |
| US 11,807,867 | Compositions and Methods for Treating Non-Age-Associated Hearing Impairment in a Human Subject In force · Medium confidence | In force | Medium confidence | |
| US 12,077,773 | Compositions and Methods for Treating Non-Age-Associated Hearing Impairment in a Human Subject In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 16: 2 patents in force now held by others. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
15 pending · 6 abandoned · 2 no status recorded